- Home
- ISRL vs ZTEK Comparison
ISRL vs ZTEK Comparison
Compare ISRL & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRL
- ZTEK
- Stock Information
- Founded
- ISRL 2021
- ZTEK 2008
- Country
- ISRL United States
- ZTEK Canada
- Employees
- ISRL N/A
- ZTEK N/A
- Industry
- ISRL Blank Checks
- ZTEK Major Chemicals
- Sector
- ISRL Finance
- ZTEK Industrials
- Exchange
- ISRL Nasdaq
- ZTEK Nasdaq
- Market Cap
- ISRL 79.3M
- ZTEK 89.3M
- IPO Year
- ISRL 2023
- ZTEK N/A
- Fundamental
- Price
- ISRL $12.35
- ZTEK $0.80
- Analyst Decision
- ISRL
- ZTEK
- Analyst Count
- ISRL 0
- ZTEK 0
- Target Price
- ISRL N/A
- ZTEK N/A
- AVG Volume (30 Days)
- ISRL 1.6K
- ZTEK 96.9K
- Earning Date
- ISRL 01-01-0001
- ZTEK 11-14-2025
- Dividend Yield
- ISRL N/A
- ZTEK N/A
- EPS Growth
- ISRL N/A
- ZTEK N/A
- EPS
- ISRL 0.14
- ZTEK N/A
- Revenue
- ISRL N/A
- ZTEK $678,078.00
- Revenue This Year
- ISRL N/A
- ZTEK N/A
- Revenue Next Year
- ISRL N/A
- ZTEK N/A
- P/E Ratio
- ISRL $91.70
- ZTEK N/A
- Revenue Growth
- ISRL N/A
- ZTEK 2519.47
- 52 Week Low
- ISRL $11.22
- ZTEK $0.62
- 52 Week High
- ISRL $14.00
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- ISRL 46.89
- ZTEK 45.73
- Support Level
- ISRL $12.20
- ZTEK $0.78
- Resistance Level
- ISRL $12.49
- ZTEK $0.90
- Average True Range (ATR)
- ISRL 0.07
- ZTEK 0.07
- MACD
- ISRL -0.00
- ZTEK -0.00
- Stochastic Oscillator
- ISRL 50.00
- ZTEK 17.87
About ISRL Israel Acquisitions Corp
Israel Acquisitions Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.